Correlation Between Algernon Pharmaceuticals and Pharming Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and Pharming Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and Pharming Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algernon Pharmaceuticals and Pharming Group NV, you can compare the effects of market volatilities on Algernon Pharmaceuticals and Pharming Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of Pharming Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and Pharming Group.

Diversification Opportunities for Algernon Pharmaceuticals and Pharming Group

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Algernon and Pharming is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and Pharming Group NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharming Group NV and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with Pharming Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharming Group NV has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and Pharming Group go up and down completely randomly.

Pair Corralation between Algernon Pharmaceuticals and Pharming Group

Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 3.83 times more return on investment than Pharming Group. However, Algernon Pharmaceuticals is 3.83 times more volatile than Pharming Group NV. It trades about 0.0 of its potential returns per unit of risk. Pharming Group NV is currently generating about -0.02 per unit of risk. If you would invest  8.23  in Algernon Pharmaceuticals on September 24, 2024 and sell it today you would lose (4.09) from holding Algernon Pharmaceuticals or give up 49.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.81%
ValuesDaily Returns

Algernon Pharmaceuticals  vs.  Pharming Group NV

 Performance 
       Timeline  
Algernon Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Algernon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Pharming Group NV 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pharming Group NV are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Pharming Group may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Algernon Pharmaceuticals and Pharming Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Algernon Pharmaceuticals and Pharming Group

The main advantage of trading using opposite Algernon Pharmaceuticals and Pharming Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, Pharming Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharming Group will offset losses from the drop in Pharming Group's long position.
The idea behind Algernon Pharmaceuticals and Pharming Group NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities